Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Be older than 2 years and younger than 16 years old, with no genetic conditions
- Have been recently diagnosed with a mild-to-moderate form of Crohn's disease, based on specific scoring measurements used by doctors (confirm with trial site)
- Have not had any changes to their medications or medication doses for at least 1 week before the treatment begins
- Be willing to have regular colonoscopies (a procedure where a camera is used to look inside the bowel) as part of the trial
Who may not be able to join:
- Patients whose doctors first treated their Crohn's disease with certain strong medications, including steroids (corticosteroids), methotrexate, thiopurines, or anti-TNF drugs (a type of medication that targets inflammation) (confirm with trial site if you are unsure which medicines your child has taken)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhihua Huang, Tongji Hospital
Phone: 15871365900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical remission; Endoscopic remission; Mucosal healing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.